Observing predictors of pituitary tumor recurrence
Official title: Pituitary Tumor Surveillance: Pathogenetic Correlation
Run by Cedars-Sinai Medical Center · NCT00599092 · Data updated 2026-11-12
This study looks at what factors might cause pituitary tumors to come back or stay active in patients who have had these tumors.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1250 (estimated) |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | January 1997 |
| Main results expected | December 2050 |
| Study ends | December 2050 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT00599092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with confirmed pituitary disease.
✕Probably not a fit
Patients without confirmed pituitary disease will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to observe the predictors of recurrence and markers of persistent disease activity in patients with pituitary mass lesions. It involves the computerized collection of comprehensive demographic, therapeutic, pathologic, and outcome information from these patients. By analyzing this data, researchers hope to identify factors that contribute to tumor recurrence and ongoing disease activity.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management strategies for patients with pituitary tumors.
How similar studies have gone: While this approach is observational, similar studies have shown success in identifying predictors of tumor recurrence in other types of cancers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with confirmed pituitary disease Exclusion Criteria: * patients who do not have confirmed pituitary disease
Where it's running
-
Cedars-Sinai Medical Center, Pituitary Center
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Shlomo Melmed, MD — Cedars-Sinai Medical Center, Pituitary Center
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding the tumor’s immune environment in pituitary tumors
This study tests how the tumor’s immune surroundings relate to pituitary tumors to help guide future treatments.
-
Investigating molecular differences in invasive pituitary tumors
This study is trying to find out what makes invasive pituitary tumors more aggressive by looking at tumor samples from patients and comparing their molecular differences.
-
Understanding genetic causes of neuroendocrine tumors in Mexican patients
This study is trying to find out the genetic changes that cause neuroendocrine tumors in Mexican patients to help develop better treatments.
-
Evaluating Enhanced Recovery After Surgery for Pituitary Tumor Patients
This study is testing whether following a special recovery plan after surgery helps people with pituitary tumors heal better and faster.
-
Evaluating nasal saline irrigations after pituitary surgery
This study tests if using nasal saline rinses after pituitary surgery can help patients recover better and improve their overall results.
-
Evaluating the CONVIVO System for Brain Tumor Surgery
This study is testing a new imaging tool during brain tumor surgery to see if it can better tell the difference between healthy and unhealthy brain tissue for patients with brain tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.